Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 14, 2014; 20(38): 13667-13680
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13667
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13667
Subtotal gastrectomy for gastric cancer
Roberto Santoro, Eugenio Santoro, Giuseppe M Ettorre, Department of General Surgery and Transplantation, San Camillo-Forlanini General Hospital, 00152 Rome, Italy
Author contributions: The idea was proposed by Santoro R; Santoro R and Ettorre GM drafted the initial manuscript; Santoro E reviewed and edited the draft; all authors approved the final manuscript before submission.
Correspondence to: Roberto Santoro, MD, PhD, Department of General Surgery and Transplantation, San Camillo-Forlanini General Hospital, Circ Gianicolense 87, 00152 Rome, Italy. santoro_roberto@fastwebnet.it
Telephone: +39-6-58705408 Fax: +39-6-58704719
Received: October 28, 2013
Revised: June 10, 2014
Accepted: June 26, 2014
Published online: October 14, 2014
Revised: June 10, 2014
Accepted: June 26, 2014
Published online: October 14, 2014
Core Tip
Core tip: Gastric cancer surgical resection with curative intent is the only treatment providing hope for cure. Gastrectomy with lymph node dissection remains a challenging procedure, which should abide by well-defined oncological principles. Subtotal gastrectomy is the treatment of choice for middle and distal-third gastric cancer; however, due to the necessity of a more extended procedure at advanced stages and the trend for more conservative treatments in early gastric cancer, the indication for conventional subtotal gastrectomy depends on multiple variables. This review aims to define the actual landmarks of this procedure and the role it plays compared to the whole range of new and old treatment methods.